Wanounou, Maor
Caraco, Yoseph
Levy, René H.
Bialer, Meir http://orcid.org/0000-0003-2046-4171
Perucca, Emilio
Article History
Accepted: 26 June 2022
First Online: 27 July 2022
Declarations
:
: This work was not supported by any funding source.
: MW, YC, and RHL do not have any conflict of interest to disclose. MB has received consultancy fees from Boehringer Ingelheim, Medison, Pharma 2B, Rekah-Vitamned, and Xenon Pharmaceuticals. EP has received speaker and/or consultancy fees from Angelini, Arvelle, Biogen, Biopas, Eisai, GW Pharma, PMI Life Sciences, Sanofi group of companies, SKL Life Science, Takeda, UCB Pharma, Xenon Pharma, and Zogenix, and royalties from Wiley, Elsevier, and Wolters Kluwers.
: Not applicable.
: Not applicable.
: All authors consent to publication of this article.
: Not applicable because this is a review article.
: Not applicable.
: MW produced an initial draft of the manuscript and conducted a literature search under guidance and supervision from MB, YC, and EP. MB, YC, RHL, and EP contributed to critical evaluation of the data and to revision and finalization of the manuscript.
: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Free to read: This content has been made available to all.